Equity Analysis /
United States of America

US : ANI Pharmaceuticals, Inc. - ANIP | 4Q21 Results: Gx Pricing Dynamics Bag Another '22 Guide, Maintain MO2 On Longer-Term Outlook

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    25 March 2022
    Published by